Patents by Inventor Arnaud Chene

Arnaud Chene has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunogenic construct comprising an EBV-cell antigen and a targeting moiety and applications thereof
    Patent number: 11147868
    Abstract: The present invention generally relates to an immunogenic construct, useful for redirecting an EBV-existing immune response towards an undesired target cell and/or microorganism, to methods for preparing said conjugate, to a pharmaceutical applications comprising said conjugate, and to medical applications thereof.
    Type: Grant
    Filed: December 15, 2016
    Date of Patent: October 19, 2021
    Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université de Paris, Institut National Transfusion Sanguine
    Inventors: Arnaud Chene, Benoit Gamain, Stéphane Gangnard
  • IMMUNOGENIC CONSTRUCT COMPRISING AN EBV-CELL ANTIGEN AND A TARGETING MOIETY AND APPLICATIONS THEREOF
    Publication number: 20180360950
    Abstract: The present invention generally relates to an immunogenic construct,useful for redirecting an EBV-existing immune response towards an undesired target cell and/or microorganism, to methods for preparing said conjugate, to a pharmaceutical applications comprising said conjugate, and to medical applications thereof.
    Type: Application
    Filed: December 15, 2016
    Publication date: December 20, 2018
    Applicants: Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universite Paris Diderot Paris 7, Institute National Transfusion Sanguine
    Inventors: Arnaud Chene, Benoit Gamain, Stéphane Gangnard